ICP devices are used to measure the pressure within the skull caused by accidents, injuries, and trauma. The ICP monitoring also has post-operative and diagnostic applications for patients suffering from cranial damage caused due to stroke, hydrocephalus, or other reasons. ICP devices help surgeons save the lives of patients suffering from these injuries with the help of proper treatment and timely intervention. Generally, there are two types of ICP monitors: one provides ICP data, whereas the other is capable of concurrent cerebrospinal fluid drainage.
Integra LifeSciences Holdings Corp and RAUMEDIC AG – Notable Market Players in Intracranial Pressure (ICP) Monitoring Devices Market
Market leaders operating in the market have undertaken various organic growth strategies in the neurotoxins market. The intracranial pressure (ICP) monitoring devices market majorly consists of the players Natus Medical Inc; RAUMEDIC AG; Sophysa SA; Integra LifeSciences Holdings Corp; Medtronic Plc; Braincare Desenvolvimento e Inovacao Tecnologica SA; NovaSignal Corp; Digitimer Ltd; Longeviti Neuro Solutions LLC, and Spiegelberg GmbH & Co KG. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals.
Below is the list of inorganic growth strategies done by the players operating in the intracranial pressure (ICP) monitoring devices market:
|
Date |
Development |
Category |
Description |
|
Feb-2023 |
NovaSignal announced the donation of NovaGuide 2 intelligent ultrasound system to Jacobs Institute |
Company News |
NovaSignal announced donating a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA, to advance stroke research and use real-time neuromonitoring to detect and help prevent intraprocedural cardiovascular and neurovascular complications in the region. |
|
Jan-2023 |
Natus Medical Incorporated Acquired Micromed Holding SAS |
Merger & Acquisition |
Natus Medical Incorporated announced the closing of its acquisition of Micromed Holding SAS (“Micromed”), a global provider of neurophysiology solutions. Micromed products will be added to the Natus Neuro portfolio and developed alongside Natus technologies. |
|
Apr-2022 |
Natus Medical to go private in $1.2B private equity acquisition deal |
Product Launch |
The device maker has agreed to be acquired by healthcare-focused private equity firm ArchiMed in a deal that would value it at about $1.2 billion and remove it from public trading. The company’s board of directors has already unanimously approved the agreement and is recommending shareholders follow suit. |
|
Aug-2022 |
Integra pulls intracranial pressure monitors for inaccurate readings. |
Product News |
Integra LifeSciences announced an immediate global voluntary removal of its CereLink intracranial pressure monitors after receiving reports from some customers that their readings were out of range. The Princeton, N.J.-based, medical device manufacturer is investigating the problems. |
|
Nov-2022 |
IRRAS Partnerd with Medtronic in the United States for its IRRAflow System |
Partnership |
IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced it had signed a Sales Agency Agreement to promote its IRRAflow system in the United States with Medtronic. |
Source: Press Release, Newsletters, and Company Annual Report
